We are a Ukrainian company. We stand with our colleagues, friends, family, and with all people of Ukraine. Learn more
BACK TO GETPROSPECT

Genmab

Email address and contacts

Genmab company description

Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Our headquarter is in Copenhagen, Denmark with sites in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. We are the creators of three marketed products* and have a broad clinical and pre-clinical product pipeline. Genmab's technology consists of validated and proprietary next-generation antibody platforms - DuoBody® for generation of bispecific antibodies; HexaBody®, which creates effector-function enhanced antibodies; HexElect®, which combines two co-dependently acting HexaBody molecules to introduce selectivity while maximizing therapeutic potency; and DuoHexaBody®, which enhances the potential potency of bispecific antibodies through hexamerization. Our core values are: • Passion for innovation • Determination—being the best at what we do • Integrity—we do the right thing • We work as one team and respect each other Our core purpose is to improve the lives of patients with cancer by creating and developing innovative and differentiated antibody products. We are also highly committed to building a sustainable and socially responsible biotech. To learn more about our technology, products, and people, please visit www.genmab.com Disclaimer: http://bit.ly/GENDisclaimer * Out-licensed products marketed by partner

Key Employees

?
************
Senior Research Associate
Find Email
L
Lance Hall Jr Cpa Mba
Senior Finance Associate, Technical Accounting
A
Ana Rita Lourenço
Scientist
L
Lonni Sommer
Senior Supply Chain Planner
J
Jessica Dumay
Research Associate
M
Mette Ravn
Senior Clinical Database Manager
D
Dereck Lafontant
Senior Project Manager
Sign up to open these and 5 more emails in Genmab
Message error line

Genmab competitors and alternatives

Alnylam Pharmaceuticals
Biotechnology
2114 employees
The Jackson Laboratory
Biotechnology
1990 employees
Foundation Medicine
Biotechnology
1916 employees
STEMCELL Technologies
Biotechnology
1752 employees
Tempus Labs, Inc.
Biotechnology
1745 employees
Kemin Industries
Biotechnology
1731 employees
View all competitors

Recently updated team members of Genmab

F
Farshid Alemdehy
Scientist, Early Stage Translational Research
C
César Oliveira Costa
Principal Research Associate Protein Production & Chemistry
M
Marieke Baas - de Ruijter
Research Associate
J
Joke Van Bemmel Phd Pmp
Associate Director Enterprise Project Management
N
Nate Ross
Global Marketing Director
S
Sipke Sangers
Senior Scientist, Analytical Science
View all employees

GetProspect Email Finder

Retrieve thousands of email addresses in single click without leaving your current tab. Download for free now!

50 Free emails every month

Add to Chrome

500+ reviews 60,000+ users

Try email finder for Free and reach your ideal customer